NCT00501163 Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients Status COMPLETED Phase N/A
NCT00500695 Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness Status COMPLETED Phase PHASE1
NCT00500201 A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. Status COMPLETED Phase PHASE1
NCT00499044 A Comparison of Two Cognitive Batteries in People With Schizophrenia Status COMPLETED Phase NA
NCT00498550 Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual Status COMPLETED Phase PHASE4
NCT00498004 Quality of Life (QOL) in Female Patient With Schizophrenia Status TERMINATED Phase PHASE4
NCT00495352 The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia Status COMPLETED Phase PHASE4
NCT00495118 A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients. Status COMPLETED Phase PHASE3
NCT00492336 Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia Status COMPLETED Phase PHASE4
NCT00488891 The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia Status TERMINATED Phase N/A
NCT00488319 Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. Status COMPLETED Phase PHASE3
NCT00488163 Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00487942 Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits Status COMPLETED Phase PHASE2
NCT00486798 FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis Status TERMINATED Phase PHASE3
NCT00485901 Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia Status COMPLETED Phase PHASE3